Jack S. Mandel, Ph.D., MPH
Senior Fellow
Health Sciences
Menlo Park

Dr. Jack S. Mandel is a Senior Fellow at Exponent. Most recently he was Professor and Director of the Dalla Lana School of Public Health, University of Toronto. From 2002-2008, Dr. Mandel was at Emory University in Atlanta where he served as Rollins Professor and Chair of the Department of Epidemiology, in the Rollins School of Public Health and Deputy Director for Cancer Control and Population Sciences in the Winship Cancer Institute. While at Emory, he was selected as a Georgia Cancer Coalition (GCC) Distinguished Cancer Scholar. From 1999-2002, Dr. Mandel was a Group Vice President of Exponent.

Dr. Mandel was a member of the University of Minnesota faculty from 1975-1999. From 1995 to 1999, he was the Head of the Division of Environmental and Occupational Health in the School of Public Health. In 1996, he received the distinguished honor of being named to the endowed Mayo Chair in Public Health. In 1997, he was the recipient of the Leonard M. Schuman Award for Excellence in Teaching. During his tenure at the University of Minnesota, Dr. Mandel served on a number of international, national, state, and local committees. He has also served as a consultant to industry, professional associations, and governmental agencies.

Dr. Mandel has conducted many case-control, cohort (both prospective and retrospective), cross-sectional, experimental, and methodological studies. He has published more than 200 articles related to epidemiology, including studies of prostate, colorectal, kidney, pancreatic, breast, lung, stomach, hematopoietic and skin cancers. These studies have evaluated a variety of potential etiologic factors including occupational exposures, radiation, pesticides and other chemicals, hormones, medications, diet, alcohol, and tobacco, as well as other lifestyle factors.

CREDENTIALS & PROFESSIONAL HONORS

  • Ph.D., Epidemiology, University of Minnesota, 1981
  • M.P.H., Epidemiology, University of Minnesota, 1973
  • B.Sc., Mathematics, University of Manitoba, 1966
  • Georgia Cancer Coalition Distinguished Cancer Scholar, 2003–2008

    Leonard M. Schuman Award for Excellence in Teaching, 1997

    Excellence in Teaching Award, 1988–1989

    Health Scientist Fellowship from the Department of National Health and Welfare, Ottawa, Canada, 1972–1975

Publications

Boffetta P, Fordyce TA, Mandel JS. A mortality study of beryllium workers. Cancer Medicine 2016; doi: 10.1002/cam4.918

Young GP, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig R, Bossuyt PMM, De Silva M, Guittet L, Halloran SP, Haug U, Hoff G, Itzkowitz SH, Leja M, Levin B, Meijer GA, O'Morain CA, Parry S, Rabeneck L, Rozen P, Saito H, Schoen RE, Seaman HE, Steele RJC, Sung JJY, Winawer SJ. Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer. Cancer 2016; 122(6):826-839.

Breckenridge CB, Berry C, Chang ET, Sielken RL Jr, Mandel JS. Association between Parkinson's Disease and cigarette smoking, rural living, well-water consumption, farming and pesticide use: systematic review and meta-analysis. PLoS One. 2016; Apr 7;11(4):e0151841. doi: 10.1371.

Chang ET, Adami HO,Boffetta P, Wedner HJ, Mandel JS. A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans. Crit Rev Toxicol 2016; 46(4): 279-331.

Chang ET, Boffetta P, Adami HO, Mandel JS. A critical review of the epidemiology of Agent Orange or 2,3,7,8-tetrachlorodibenzo-p-dioxin and lymphoid malignancies. Ann Epidemiol 2015; 25(4):275-292.

Goodman M, Narayan KMV, Flanders D, Chang ET, Adami HO, Boffetta P, Mandel JS. Dose-response relation between serum TCDD and diabetes mellitus: a meta-analysis. Am J Epidemiol. 2015;181:374-384.

Boffetta P, Fordyce T, Mandel JS. A mortality study of workers exposed to insoluble forms of beryllium. Eur J Cancer Prev 2014; 23(6):587-593.

Chang ET, Boffetta P, Adami HO, Cole P, Mandel JS. A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer. Eur J Epidemiol 2014; 29(10):667-723

Chang ET, Adami HO, Boffetta P, Cole P, Starr TB, Mandel JS. A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans. Crit Rev Toxicol 2014; 44(S1):1-81.

Goodman M, Mandel JS, DeSesso JM, Scialli AR. Atrazine and pregnancy outcomes: a systematic review of epidemiologic evidence. Birth Defects Res B Dev Reprod Toxicol 2014; 101(3):215-236.

Boffetta P, Donaldson K, Moolgavkar S, Mandel JS. A systematic review of occupational exposure to synthetic vitreous fiber and mesothelioma. Crit Rev Toxicol 2014; 44(5): 436-449.

Chang ET, Adami HO, Bailey WH, Boffetta P, Kreiger RI, Moolgavkar SH, Mandel JS. Validity of geographically modeled environmental exposure estimates. Crit Rev Toxicol 2014; 44(5): 450-466.

Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, Church TR. Long-term mortality after screening for colorectal cancer. New Engl J Med 2013; 369:1106-1114.

Ruder AM, Yiin JH, Waters MA, Carreon T, Hein MJ, Butler MA, Calvert GM, Davis-King KE, Schulte PA, Mandel JS, Morton RF, Reding DJ, Rosenman KD, Stewart PA. The Upper Midwest Health Study: gliomas and occupational exposure to chlorinated solvents. Occup Environ Med 2013; 70:73-80.

Boffetta P, Adami HO, Berry SC, Mandel JS. Atrazine and cancer: a review of the epidemiologic evidence. Eur J Cancer Prev 2013; 22(2):169-180.

Mink PJ, Mandel JS, Sceurman BK, Lundin JI. Epidemiologic studies of glyphosate and cancer: a review. Regul Toxicol Pharmacol 2012;63:440-452.

Ruder AM, Waters MA, Carreon T, Butler MA, Calvert GM, Davis-King KE, Waters KM, Schulte PA, Mandel JS, Morton RF, Reding DJ, Rosenman KD. The Upper Midwest Health Study: industry and occupation of glioma cases and controls. Am J Ind Med 2012; 55:747-755.

Yiin JH, Ruder AM, Stewart PA, Waters MA, Carreón T, Butler MA, Calvert GM, Davis-King KE, Paul A Schulte, Mandel JS, Morton RF, Reding DJ, Rosenman KD. The Upper Midwest Health Study: a case-control study of pesticide applicators and risk of glioma. Environ Health 2012;11:39-52

Rodu B, Cole P, Mandel JS. Evaluation of the national toxicology program on carcinogens. Regul Toxicol Pharmacol 2012;64:186-188.

Mandel JS, Adami HO, Cole P. Paraquat and Parkinson's Disease: An overview of the epidemiology and a review of two recent studies. Regul Toxicol Pharmacol 2011.

Boffetta P, Fryzek J, Mandel JS. Occupational exposure to beryllium and cancer risk: A review of the epidemiologic evidence. Crit Rev Toxicol 2011.

Mandel JS, Smith R. Principles of cancer screening. In: Cancer: Principles and Practices of Oncology. DeVita VT, Lawrence TS, Rosenberg SA, DePinho RA, Weinberg RA (eds), Lippincott, Williams and Wilkins. 9th edition, 2011.

Church TR, Mandel JS. Screening for Gastrointestinal Cancers. In: Cancer: Principles and Practices of Oncology. Ed: DeVita VT, Lawrence TS, Rosenberg SA, DePinho RA, Weinberg RA. Lippincott, Williams and Wilkins, 9th edition, 2011.

Buffler PA, Ginevan ME, Mandel JS, Watkins DK. The Air Force Health Study: an epidemiologic retrospective. Ann Epidemiol 2011;21(9):673-687.

Boffetta P, Mundt KA, Adami HO, Cole P, Mandel JS. TCDD and cancer: a critical review of epidemiologic studies. Crit Rev Toxicol 2011 41:622-636.

Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol 2011;26(suppl 1):1-58.

Sathiakumar N, MacLennan PA, Mandel J, Delzell E. A review of epidemiologic studies of triazine herbicides and cancer. Crit Rev Toxicol 2011;41 Suppl 1:1-34.

Mink PJ, Mandel JS, Lundin JI, Sceurman BK. Epidemiologic studies of glyphosate and non-cancer health outcomes: A review. Regul Toxicol Pharmacol 2011;61:172-184.

Cole P, Adami HO, Trichopoulos D, Mandel JS. Formaldehyde and lymphohematopoietic cancers: a review of two recent studies. Regul Toxicol Pharmacol 2010;58:161-166.

Cole P, Adami HO, Trichopoulos D, Mandel JS. Formaldehyde and Lymphohematopoietic Cancers: A Review of Two Recent Studies. In press.

Doria-Rose VP, Marcus PM, Miller AB, Bergstralh EJ, Mandel JS, Tockman MS, Prorok PC. Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials. Clin Trials 2010; 7:69-77.

Boffetta P, Adami HO, Cole P, Trichopoulos D, Mandel JS. Epidemiologic studies of styrene and cancer: a review of the literature. J Occup Environ Med 2009; 51(11):1275-1287.

Ruder AM, Carreón T, Butler MA, Calvert GM, Davis-King KE, Waters MA, Schulte PA, Mandel JS, Morton RF, Reding DJ, Rosenman KD, and the Brain Cancer Collaborative Study Group. Exposure to farm crops, livestock and farm tasks and risk of glioma. The Upper Midwest Health Study. Am J Epidemiol 2009; 169:1479-1491.

Cole P, Mandel S, Collins JJ. Acrylonitrile and cancer: a review of the epidemiology. Regul Toxicol Pharmacol 2008; 52:342-351.

Goodman M, Bostick RM, Dash C, Terry P, Flanders WD, Mandel J. A summary measure of pro- and anti-oxidant exposures and risk of incident, sporadic, colorectal adenomas. Cancer Causes and Control 2008; 35:1051-1064.

Mandel JS, Smith R. Principles of Cancer Screening. In: Cancer: Principles and Practices of Oncology. Ed: DeVita VT, Lawrence TS, Rosenberg SA. Lippincott:Williams and Wilkins. 2008.

Church TR, Mandel JS. Screening for Gastrointestinal Cancers. In: Cancer: Principles and Practices of Oncology. Ed: DeVita VT, Lawrence TS, Rosenberg SA. Lippincott:Williams and Wilkins. 2008.

Mandel JS. Screening for Colorectal Cancer. In: Gastroenterology Clinics of North America. Ed: Cappell MS. Elsevier Inc. 2008; 37:97-115.

Morikawa A, Varma V, Gillespie TW, Lyles RH, Goodman M, Bostick RM, Mandel JS, Zhou W. Counting alleles in single lesions of prostate tumors among ethnically diverse patients. Prostate 2008; 68:231-40.

Mink PJ, Adami HO, Trichopoulos D, Britton NL, Mandel JS. Pesticides and prostate cancer: a review of epidemiologic studies with specific agricultural exposure information. Eur J Cancer Prev 2008; 17:97-110.

Cornelissen G, Siegelova J, Abramson J, Sundaram B, Mandel J, Holley D, Halberg F. Body mass index (BMI), pulse pressure (PP) and premetabolic syndrome. In: Halberg F, Kenner T, Fiser B, Siegelova J, eds. Proceedings, Noninvasive Methods in Cardiology, Brno, Czech Republic, October 4-7, 2008. p. 116-123.

Mandel JS. Which colorectal cancer screening test is best? JNCI 2007; 99:1424-5.

Alexander BH, Mandel JS, Baker BA, Burns CJ, Bartels MJ, Acquavella JF, Gustin C. Biomonitoring of 2,4-Dichlorophenoxyactic acid exposure and dose in farm families. Environ Health Persp 2007; 115:370-376.

Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER, for the Polyp Prevention Study Group. A randomized trial of folic acid for the prevention of colorectal adenomas. JAMA 2007; 297: 2351-9.

Goodman M, Bostick RM, Dash C, Flanders WD, Mandel JS. Oxidative stress score as a combined measure of pro-oxidant and anti-oxidant exposures. Ann Epidemiol 2007; 17:394-9.

Grau MV, Baron JA, Sandler RS, Wallace K, Haile RW, Church TR, Beck GJ, Summers RW, Barry EL, Cole BF, Snover DC, Rothstein R, Mandel JS. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst 2007; 99:129-36.

Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, Trichopoulos D. The non-Hodgkin lymphomas: A review of the epidemiologic literature. Int J Cancer 2007; 120 Suppl 12:1-39.

Alexander DD, Mink PJ, Adami HO, Cole P, Mandel JS, Oken MM, Trichopoulos D. Multiple myeloma: A review of the epidemiologic literature. Int J Cancer 2007;120 Suppl 12:40-61.

Goodman M, Bostick RM, Dash C, Terry P, Flanders D, Mandel J. A summary measure of pro- and anti-oxidant exposures in relation to colorectal adenoma. Proc AACR Special Conference: Approaches to Complex Pathways in Molecular Epidemiology, 2007; B3.

Scher DP, Alexander BH, Adgate JL, Eberly LE, Mandel JS, Acquavella JF, Bartels MJ, Brzak KA. Agreement of pesticide biomarkers between morning void and 24-h urine samples from farmers and their children. Journal Exp Sci Environ Epidemiol. 2007; 17(4):350-7.

Issa MM, Zasada W, Ward K, Hall JA, Petros JA, Ritenour CWM, Goodman M, Kleinbaum D, Mandel J, Marshall FF. The value of digital rectal examination as a predictor of prostate cancer diagnosis among US Veterans referred for prostate biopsy. Cancer Detect Prev.2006; 30:269-75.

Goodman M, Bostick RM, Ward KC, Terry P.,van Gils CH, Taylor JA, Mandel JS. Lycopene intake and prostate cancer: effect modification by plasma antioxidants and the XRCC1 genotype. Nutr Cancer 2006; 55:13-20.

Ruder AM, Waters MA, Carreón T, Butler MA, Davis-King KE, Calvert GM, Schulte PA, Ward EM, Connally LB, Lu J, Wall D, Zivkovich Z, Heineman EF, Mandel JS, Morton RF, Reding DJ, Rosenman KD, Brain Cancer Collaborative Study Group. The Upper Midwest Health Study: A case-control study of glioma in rural residents. J Ag Safe Health 2006; 12: 255-274.

Alexander BH, Burns C, Bartels MJ, Acquavella JF, Mandel JS, Gustin C, Baker BA. Chlorpyrifos exposure in farm families: results from the farm family exposure study. J Expo Sci Environ Epidemiol. 2006 Mar 29; [Epub ahead of print]

Grau MV, Baron JA, Langholz B, Karagas M, Greenberg ER, Stukel TA, Mandel JS. The effect of NSAIDs on the recurrence of nonmelanoma skin cancer. Int J Cancer. 2006; 119:682-6.

Ruder AM, Waters MA, Butler MA, Carreón T, Calvert GM, Davis-King KE, Schulte PA, Sanderson WT, Ward EM, Connally LB, Heineman EF, Mandel JS, Morton RF, Reding DJ, Rosenman KD, Talaska G, Brain Cancer Collaborative Study Group. Gliomas and farm pesticide exposure in men: The Upper Midwest Health Study. Arch Environ Health 2004; 59: 650-657 (published June 2006).

Acquavella J, Alexander B, Mandel J, Burns C, Gustin C. Exposure misclassification in epidemiologic studies of agricultural pesticides: insights from biomonitoring studies of farmers. Epidemiology 2006; 17:69-74.

Mandel JS. Screening of patients at average risk for colon cancer. In: Colon Cancer Screening, Surveillance, Prevention and Treatment: Conventional and Novel Technologies. Cappell MS (ed) Med Clin N Am 2005; 89:43-59.

Grau MV, Baron JA, Barry EL, Sandler RS, Haile RW, Mandel JS Cole BF. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2005; 14:2353-8.

Baker BA, Alexander BH, Mandel JS, Acquavella JF, Honeycutt R, Chapman P. Farm Family Exposure Study: methods and recruitment practices for a biomonitoring study of pesticide exposure. J Expo Anal Environ Epidemiol 2005; 15:491-9.

Mandel JS, Alexander BH, Baker B, Acquavella JF, Chapman P, Honeycutt R. Biomonitoring for farm families in the Farm Family Exposure Study. Scand J Work Environ Health 2005; 31 suppl 1:98-104.

Robertson DJ, Greenberg ER, Beach M, Sandler RS, Ahnen D, Haile RW, Burke CA, Snover DC, Bresalier RS, McKeown-Eyssen G, Mandel JS, Bond JH, van Stolk RU, Summers RW, Rothstein R, Church TR, Cole B, Byers T, Mott L, Baron JA. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterol 2005; 129:34-41.

Carreon T, Butler MA, Ruder AM, Waters MA, Davis-King KE, Calvert GM, Schulte PA, Connally B, Ward EM, Sanderson WT, Heineman EF, Mandel JS, Morton RF, Reding DJ, Rosenman KD, Talaska G. Gliomas and farm pesticide exposure in women: the upper Midwest health study. Env Health Persp 2005; 113: 546-51.

Baron JA, Beach M, Wallace K, Grau MV, Sandler RS, Mandel JS, Heber D, Greenberg ER. Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 2005; 14:586-9.

Acquavella JF, Gustin C, Alexander B, Mandel JS. Implications for epidemiologic research on variation by pesticide in studies of farmers and their families. Scand J Work Environ Health 2005; 31 suppl 1:105-109.

Winawer S, Faivre J, Selby J, Bertaro L, Chen TH, Kronborg O, Levin B, Mandel J, O’morain C, Richards M, Rennert G, Russo A, Saito H, Semigfnovsky B, Wong B, Smith R. Workgroup II. The screening process. UICC International Workshop on facilitating screening for colorectal cancer. Ann Oncol 2005; 16:31-3.

Huang K, Whelan EA, Ruder AM, Ward EM, Deddens JA, Davis-King KE, Carreon T, Waters MA, Butler MA, Calvert GM, Schulte PA, Zivkovich Z, Heineman EF, Mandel JS, Morton RF, Reding DJ, Rosenman KD. Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev 2004; 13:1583-8.

Zhou W, Goodman M, Lyles RH, Lim SD, Williams TY, Rusthoven KE, Mandel JS, Amin MB Petros JA. Surgical margin and Gleason score as predictors of post-operative recurrence in prostate cancer with or without chromosome 8p allelic imbalance. Prostate 2004; 61:81-91.

Oakley GP, Mandel JS. Commentary: Folic acid fortification remains an urgent health priority. Br Med J 2004; 329:1376 (Letter).

Wallace K, Baron JA, Cole BF, Sandler RS, Karagas MR, Beach ML, Haile RW, Burke C, Pearson L, Mandel JS, Rothstein R, Snover D. The effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst 2004; 96:921-5.

Goodman M, Mandel JS. Progression rates of colorectal cancer in high risk individuals. Cancer 2004;10:153-5.

Hessel PA, Kalmes R, Smith TJ, Lau E, Mink PJ, Mandel JS. A nested case-control study of prostate cancer and atrazine. J Occup Environ Med 2004; 46:379-85.

Acquavella JF, Alexander BH, Mandel JS, Gustin C, Baker B, Chapman P, Bleeke M. Glyphosate biomonitoring for farmers and their families: results from the Farm Family Exposure Study. Environ Health Perspect 2004; 112: 321-326.

Ederer F, Church T, Mandel J. Colorectal cancer screening. Scand J Gastroenterol 2004; 39:1031-2. (Letter).

Mandel JS. Sigmoidoscopy screening probably works, but how well is still unknown. J Natl Cancer Inst 2003:95:571-573.

Mandel JS, Chapman P, Amsel J. Cohort mortality study of employees at the Celanese plant in Pampa, Texas. Am J Ind Med 2003; 43:656-661.

Cole P, Trichopoulos D, Pastides H, Starr T, Mandel JS. Dioxin and cancer: A critical review. Regul Toxicol Pharmacol 2003; 38:378-388.

Baron JA, Cole B, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott L, Pearson L, Saibil F, van Stolk RU. A randomized trial of aspirin as a chemopreventive agent against colorectal adenomas. New Engl J Med 2003; 348:891-899.

Golden R, Doull J, Waddell W, Mandel J. Potential human cancer risks from exposure to PCBs: A tale of two evaluations. Critical Rev Toxicol 2003; 33:543-580.

Alexander BH, Olsen GW, Burris JM, Mandel JH, Mandel JS. Mortality study of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup Environ Med 2003; 60:722-729.

Kimbrough RD, Doemland ML, Mandel JS. A mortality update of male and female capacitor workers exposed to polychlorinated biphenyls. J Occup Environ Med 2003; 45:271-282.

Steinbuch M, D’Agostino RB, Mandel JS, Gabrielson E, McClung R, Stemhagen A, Hofman A. Assessment of mortality in patients enrolled in a risedronate clinical trial program: a retrospective cohort study. Regul Toxicol Pharmacol 2002; 35:320-326.

Banks RS, Thomas W, Mandel JS, Kaune WT, Wacholder S, Tarone RE, Linet MS. Temporal trends and misclassification in residential 60-Hz magnetic field measurements. Bioelectricmagnetics 2002; 23:196-205.

Church T, Ederer F, Mandel J. All-cause mortality in randomized trials of cancer screening. JNCI 2002; 94:861. (Letter).

Goodman M, LaVerda N, Clarke C, Foster ED, Iannuzzi J, Mandel J. Neurobehavioural testing in workers occupationally exposed to lead: systematic review and meta-analysis of publications. Occup Environ Med 2002; 59:217-223.

Mandel JS, Kelsh M. A review of the epidemiology of trichloroethylene and kidney cancer. Hum Ecol Risk Assess 2001; 7:727-735.

Greenberg RS, Mandel JS, Pastides H, Britton NL, Rudenko L, Starr TB. A meta-analysis of cohort studies describing mortality and cancer incidence among chemical workers in the U.S. and Western Europe. Epidemiology 2001; 12:727-740.

Ederer F, Church T, Mandel J. What will you be when you grow up? Gastroenterol 2001; 121:732-4. (Letter).

Mandel JS, Church TR, Ederer F. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2001; 344:1023. (Letter).

Cher DJ, Conwell JA, Mandel JS. MRI for detecting silicone breast implant rupture: meta-analysis and implications. Ann Plast Surg 2001; 47:367-380.

Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. New Engl J Med 2000; 343:1603-1607.

Prorok PC, Andriole GL, Bresalier RS, Buys S, Chia D, Crawford ED, Fogel R, GelmannEP, Gilbert F, Hasson MA, Hayes R, Johnson CC, Mandel JS, Oberman A, O’Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000; 21:273S-309S.

Sandler RS, Baron JA, Tosteson TD, Mandel JS, Haile RW. Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial. Cancer Epidemiol Biomarkers and Prev 2000; 9:653-656.

Mandel JS. Renal cell cancer correlated with occupational exposure to trichloroethylene. J Cancer Res Clin Oncol 2001; 127:265-268.

Mandel JH, Carr WP, Hillmer T, Leonard PR, Halberg JU, Sanderson WT, Mandel JS. Safe handling of agricultural pesticides in Minnesota: results of a county-wide educational intervention. J Rural Health 2000; 16:148-154.

Doody MM, Mandel JS, Linet MS, Ron E, Lubin JH, Boice JD Jr., Fraumeni JF Jr. Mortality among Catholic nuns certified as radiologic technologists. Am J Indust Med 2000; 37:339-348.

Mandel JS. Commentary on “primary prevention” by Friedlich and Stern. Surg Oncol Clin N Am 2000; 9:661-663.

Gray GM, Goldstein BD, Bailar J, Davis DL, Delzell E, Dost F, Greenberg RS, Hatch M, Hodgson E, Ibrahim MA, Lamb J, Lavy T, Mandel J, Monson R, Robson M, Shore R, Graham JD. The Federal Government’s Agricultural Health Study: A critical review with suggested improvements. Hum Ecol Risk Assess 2000; 6:47-71.

Freedman D, Linet M, Doody M, Mohan A, Alexander B, Boice J, Mandel J, Tarone R. Trends in reproductive, smoking and other chronic disease risk factors by birth cohort in a large occupational study. Ann Epidemiol 2000; 10:457-458.

Albers JW, Cole P, Greenberg RS, Mandel JS, Monson R, Ross JH, Snodgrass WR, Spurgeon A, van Gemert M. Analysis of chlorpyrifos exposure and human health: expert panel report. J Toxicol Environ Health 1999; 2:301-324.

Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS,, Rothstein R, Summers RW, Snover DC, Beck GJ. Calcium supplements and colorectal adenomas. Ann Ny Acad Sci 1999; 889:138-145.

Pheley AM, Melby D, Schenck C, Mandel J, Peterson PK. Can we predict recovery in chronic fatigue syndrome? Minn Med 1999; 82:52-56.

Ederer F, Geisser MS, Mongin SJ, Church TR, Mandel JS. Colorectal cancer deaths as determined by expert committee and from death certificate: A comparison. The Minnesota Study. J Clin Epidemiol 1999; 52:447-452.

Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: Effectiveness of biennial screening for fecal-occult blood. J Natl Cancer Inst 1999; 91:434-437.

Baron JA, Beach M, Mandel JS, VanStolk RU, Haile RW, Rothstein R, Sandler RS, Summers RW, Beck GJ, Frankl H, Bond JH, Snover DC, Pearson L, Greenberg ER. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999; 340:101-7.

Estensen RD, Levy M, Klopp SJ, Galbraith AR, Mandel JS, Blomquist JA, Wattenberg LW. N-acetylcysteine suppression of the proliferative index in the colon of patients with previous adenomatous colonic polyps. Cancer Lett 1999; 147:109-114.

Benichou J, Chow WH, McLaughlin JK, Mandel JS, Fraumeni JF Jr. Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol 1998; 148:424-430.

Olsen GW, Gilliland FD, Burlew MM, Burris JM, Mandel JS, Mandel JH. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J Occup Environ Med 1998; 40:614-622.

Mandel JS, Oken M. Etiology, prevention and treatment of breast, prostate, colorectal and lung cancer. Minn Med 1998; 81:44-46.

Hyman J, Baron JA, Dain BJ, Sandler RS, Haile RW, Mandel JS, Mott LA, Greenberg ER. Dietary and supplemental calcium and the recurrence of colorectal adenomas. Cancer Epidemiol Biomarkers and Prev 1998; 7:291-295.

Bond JH, Mandel JS, Church TR. Role of fecal occult-blood testing. N Engl J Med 1998; 339:774-5.(Letter).

Church TR, Ederer F, Mandel J. Re: Fecal occult blood screening in the Minnesota study. JNCI 1998; 90:467. (Letter).

Stoner TJ, Dowd B, Carr WP, Maldonado G, Church TR, Mandel J. Do vouchers improve breast cancer screening rates? Results from a randomized trial. Health Serv Res 1998; 33:11-28.

Bond JH, Mandel JS, Church TR. Role of fecal occult-blood testing. N Engl J Med 1998; 339:774-775
Whorton MD, Amsel J, Mandel J. Cohort mortality study of prostate cancer among chemical workers. Am J Indust Med 1998; 33:293-296.

Doody MM, Mandel JS, Lubin JH, Boice JD Jr. Mortality among United States radiologic technologists, 1926-1990. Cancer Causes and Control 1998; 9:67-75.

Baron JA, Sandler RS, Haile RW, Mandel JS, Mott LA, Greenberg ER. Folate, alcohol, cigarette smoking and the risk of colorectal adenomas. J Natl Cancer Inst 1998; 90:57-62.

Mandel J. Colorectal cancer screening. Cancer Metastasis Rev 1997; 16:263-279.

Tseng M, Sandler RS, Greenberg ER, Mandel JS, Haile RW, Baron JA. Dietary iron and recurrence of colorectal adenomas. Cancer Epidemiol Biomarkers and Prev 1997; 6:1029-1032.

Ederer F, Church TR, Mandel JS. Fecal occult blood screening in the Minnesota study: Role of chance detection of lesions. J Natl Cancer Inst 1997; 89:1423-1428.

Church TR, Ederer F, Mandel JS. Fecal occult blood screening in the Minnesota study: Sensitivity of the screening test. J Natl Cancer Inst 1997; 89:1440-1448.

Mandel JS. Screening for colorectal cancer will reduce mortality. Clinical Geriatrics 1997; 5:19-33.

Gerberich SG, Gibson R, Fife D, Mandel JS, Aeppli D, Le C, Rolnick SJ, Renier C, Burlew M, Matross R. Effects of brain injury on college academic performance. Neuroepidemiology 1997; 16:1-14.

Baron JA, Greenberg ER, Haile R, Mandel J, Sandler R, Mott L. Coffee and tea and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers & Prev 1997; 6:7-10.

Mandel JH, Carr WP, Hillmer T, Leonard PR, Halberg JU, Sanderson WT, Mandel JS. Factors associated with safe use of agricultural pesticides in Minnesota. J Rural Health 1996;12:301-310.
Carr WP, Maldonado G, Leonard PR, Halberg JU, Church TC, Mandel JH, Dowd B, Mandel JS. Mammogram utilization among farm women. J. Rural Health 1996; 12:278-290.

Mandel JS. Advances in Screening for Colorectal Cancer. In: Advances in Cancer Screening, Miller AB (ed.), Kluwer Academic Publishers, Boston, 1996.

Gilliland FD, Mandel JS. Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins and cholesterol: A study of occupationally exposed men. Am J Ind Med 1996; 29:560-568.

Schlehofer B, Pommer W, Mellemgaard A, Stewart JH, McCredie M, Niwa S, Lindblad P, Mandel JS, McLaughlin JK, Wahrendorf J. International renal cell cancer study. VI. The role of medical and family history. Int J Cancer 1996; 66:723-726.

Rothman KJ, Chow CK, Morgan R, Balzano Q, Guy AW, Funch D, Preston-Martin S, Mandel JS, Steffens R, Carlo G. Assessment of cellular telephone and other radio frequency exposure. Epidemiology 1996; 7:291-298.

Mandel JS. Screening for colon and rectal cancer. Cancer Control 1996; 3:170-177.

Greenberg ER, Baron JA, Karagas MR, Stukel TA, Nierenberg DW, Stevens MM, Mandel JS, Haile R, Ernster V. Excess mortality associated with low blood levels of beta carotene is not reduced by oral supplementation. JAMA 1996; 275:699-703.

Wolk A, Gridley G, Niwa S, Lindblad P, McCredie M, Melemgaard A, Mandel JS, Wahrendorf J, McLaughlin JK, Adami HO. International renal cell cancer study. VII. Role of diet. Int J Cancer 1996; 65:67-73.

Chow WH, McLaughlin JK, Mandel JS, Wacholder S, Niwa S, Fraumeni JF Jr. Obesity and risk of renal cell cancer. Cancer Epidemiol Biomarkers & Prev 1996; 4:17-21.

Mandel JS. Colon and Rectal Cancer. In Cancer Screening. Reintgen DS, Clark RA. (ed.) Mosby, Missouri, 1996.

Baron JA, Tosteson TD, Wargovich MJ, Sandler R, Mandel J, Bond J, Haile R, Summers R,Van Stolk R, Rothstein R, Weiss J. Calcium supplementation and rectal mucosal proliferation: A randomized controlled trial. J Natl Cancer Inst 1995; 87:1303-1307.

McLaughlin JK, Chow WH, Mandel JS, Mellemgaard A, McCredie M, Lindblad P, Schlehofer B, Pommer W, Niwa S, Adami HO. International renal cell cancer study. VIII. Role of diuretics, other antihypertensive medications and hypertension. Int J Cancer 1995; 63:216-221.

Boice JD, Mandel JS, Doody MM. Breast cancer among radiologic technologists. JAMA 1995; 274:392-401.

Thomas W, White CM, Mah J, Geisser MS, Church TR, Mandel JS. Longitudinal compliance with annual screening for fecal occult blood. Am J Epidemiol 1995; 142:176-182.

Chow WH, McLaughlin JK, Mandel JS, Wacholder S, Niwa S, Fraumeni JF. Risk of renal cell cancer in relation to diuretics, anti-hypertensive drugs and hypertension. Cancer Epidemiol Biomarkers & Prev 1995; 4:327-331.

Mandel JS, McLaughlin JK, Schlehofer B, Mellemgaard A, Helmert U, Lindblad P, McCredie M, Adami HO. International renal cell cancer study. IV. Occupation. Int J Cancer 1995; 61:601-605.

McLaughlin JK, Lindblad P, Mellemgaard A, McCredie M, Mandel JS, Schlehofer B, Pommer, W, Adami, HO. International renal cell cancer study. I. Tobacco use. Int J Cancer 1995; 60:194-198.

McCredie M, Pommer W, McLaughlin JK, Stewart JH, Lindblad P, Mandel JS, Mellemgaard A, Schlehofer B, Niwa S. International renal cell cancer study. II. Analgesics. Int J Cancer 1995; 60:345-349.

Mellemgaard A, Lindblad P, Schlehofer B, Bergstrom R, Mandel JS, McCredie M, McLaughlin JK, Niwa S, Odaka N, Pommer W, Schlehofer B, Olsen JH. International renal cell cancer study. III. Role of weight, height, physical activity and use of amphetamines. Int J Cancer 1995; 60:350-354.

Lindblad P, Mellemgaard A, Schlehofer B, Adami HO, McCredie M, McLaughlin JK, Mandel JS. International renal-cell cancer study. V. Reproductive factors, gynecological operations and exogenous hormones. Int J Cancer 1995; 61:192-198.

Doody MM, Mandel JS, Boice JD. Employment practices and breast cancer among radiation technologists. JOEM 1995; 37:321-327.

Chow WH, McLaughlin JK, Mandel JS, Blot J, Niwa S, Fraumeni JF. Reproductive factors and renal cell cancer risk among women. Int J Cancer 1995; 60:321-324.

Chow WH, McLaughlin JK, Linet MS, Mandel JS, Niwa S, Blot WJ. Use of analgesics and risk of renal cell cancer. Int J Cancer 1994; 59:467-470.

Mandel JS, Ederer F, Church T, Bond J. Screening for colorectal cancer. which test is best? JAMA 1994; 272:1099-1100.

Chow WH, Gridley G, McLaughlin JK, Mandel JS, Wacholder S, Blot WJ, Niwa S, Fraumeni JF Jr. Protein intake and risk of renal cell cancer. J Natl Cancer Inst 1994; 86:1131-1139.

Mandel JS, Church TR, Ederer F. Re: Fecal occult blood screening for colorectal cancer: Is mortality reduced by chance selection for screening solonoscopy? JAMA 1994;272:1099. (Letter).

Greenberg ER, Baron JA, Tosteson TD, Freeman DH, Beck GJ, Bond JH, Colacchio T, Coller JA, Frankl HD, Haile RW, Mandel JS, Nierenberg DW, Rothstein R, Snover DC, Stevens MM, Summers RW, VanStolk RU. A clinical trial of antioxidant vitamins to prevent colorectal adenomas. N Engl J Med 1994; 331:141-147.

Mandel J. Screening for colorectal cancer. Curr Opin Gen Surg 1994; 79-84.

Miller RF, Lohman WH, Maldonado G, Mandel JS. An epidemiologic study of carpal tunnel syndrome and hand-arm vibration syndrome in relation to vibration exposure. J Hand Surg 1994; 19A; 99-105.

Mandel JS, Korelitz JJ, O'Fallon WM. Identification of neighborhood controls and the location and recruitment of all study subjects. In: Schuman LM, Coulson AH, Mandel JS, Massey FJ, O'Fallon WM (eds.) Health Status of American Men - A Study of Post-Vasectomy Sequelae. J Clin Epidemiol 1993; 46:725-732.

Bloemen LJ, Mandel JS, Bond GG, Pollack AF, Vitek RP, Cook RR. An update of mortality among chemical workers potentially exposed to the herbicide 2,4-Dichlorophenoxyacetic acid and its derivatives. JOM 1993; 35:1208-1212.

Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Screening for fecal occult blood reduces mortality from colorectal cancer: Results from the Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328:1365-1371.

Gilliland FD and Mandel JS. Reproductive hormones and perfluorooctanoic acid: A study of occupationally exposed men. JOM 1993; 35:950-954.

Schuman LM, Coulson AH, Mandel JS, Massey FJ, O'Fallon WM. Health Status of American Men - A Study of Post-Vasectomy Sequelae. J Clin Epidemiol 1993; 46:697-958.

Korelitz JJ, Mandel JS, and O'Fallon WM. Data Collection. In: Schuman LM, Coulson AH, Mandel JS, Massey FJ, O'Fallon WM (eds.) Health Status of American Men - A Study of Post-Vasectomy Sequelae. J Clin Epidemiol 1993; 46:741-752.

Mandel JS, Church TR, Ederer F. Re: Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 329:1353-1354. (Letter)

Chang PC, Spivey GH, Mandel JS. Study Cohorts. In: Schuman LM, Coulson AH, Mandel JS, Massey FJ, O'Fallon, WM (eds.) Health Status of American Men - A Study of Post-Vasectomy Sequelae. J Clin Epidemiol 1993; 46:811-826.

Chang PC, Spivey GH, Mandel JS. Within-pair agreement. In: Schuman LM, Coulson AH, Mandel JS, Massey FJ, O'Fallon WM (eds.) Health Status of American Men - A Study of Post-Vasectomy Sequelae. J Clin Epidemiol 1993; 46:827-856.

Greenberg ER, Baron JA, Freeman DH, Mandel JS, Haile R. Reduced risk of large bowel adenomatous polyps among aspirin users. JNCI 1993; 85:912-916.

Ederer F, Church TR, Mandel JS. Sample sizes of prevention trials have been too small. Am J Epidemiol 1993; 137:787-796.

Church T, Ederer F, Mandel J, Watt G, Geisser M. Estimating the duration of prevention trials. Am J Epidemiol 1993; 137:797-810.

Johnson RA, Mandel JS, Gibson RW, Mandel JH, Bender AP, Gunderson PD, Renier CM. A comparison of data on prior pesticide use collected from self and proxy respondents. Epidemiology 1993; 4:157-164.

Zarmbinski MA, Messner RP, Mandel JS. The occurrences of anti-ds DNA antibodies in laboratory workers handling blood from SLE patients. J. Rheumatol 1992; 19:1380-1384.

Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies: I. Principles. Am J Epidemiol 1992; 135:1019-1028.

Wacholder S., Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies: II. Types of controls. Am J Epidemiol 1992; 135:1029-1041.

Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies: III. Design options. Am J Epidemiol 1992; 135:1042-1050.

Boice JD Jr, Mandel JS, Morin MM, Yoder RC, McGowan RA. A health survey of radiologic technologists. Cancer 1992; 69:586-598.

Church TR, Mandel JS, Bond JH, Ederer F, Snover DC, Bradley GM, Williams SE, Schuman LM. Colon Cancer Control Study: Status and Current Issues. In: Cancer Screening. Eds. Miller, A.B. et al., UICC, Cambridge Press, 1991.

Olsen GW, Mandel JS, Gibson RW, Wattenberg LW, Schuman LM. Nutrients and pancreatic cancer: a population-based case-control study. Cancer Causes and Control 1991; 2:291-297.

Olsen GW, Brondum J, Bodner K, Kravat B, Mandel JS, Mandel JH, Bond GG. Occupation and industry on death certificates of long-term chemical workers: Concordance with work history records. Am J Ind Med 1990; 17:465-481.

Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, Elias PM, Lowe N, Nierenberg DN, Vance JC, Bayrd G, Freeman DH, Clendenning WE, Kwan T and the Skin Cancer Prevention Study Group. A clinical trial of beta-carotene to prevent basal and squamous cell cancers of the skin. N Engl J Med 1990; 12:817.

Church TR, Bond JH, Mandel JS. Re: Sensitivity, specificity and positive predictivity of the Hemoccult test in screening for colorectal cancers. Gastroenterology 1990; 99:608-9. (Letter).

McLaughlin JK, Mandel JS, Mehl ES, Blot WJ. Reliability of next-of-kin and self respondents to questions on cigarette, coffee and alcohol consumption. Epidemiology 1990; 1:408-412.

Mandel JS. Analgesic use and chronic renal disease. N Engl J Med 1989; 321:1126. (Letter).

Mandel JS, Bond JH, Snover DC, Bradley M, Church T, Williams S, Watt G, Schuman LM, Ederer F, Gilbertsen V. Sensitivity, specificity and positive predictive value of the Hemoccult test in screening for colorectal cancers. Gastroenterology 1989; 97:597-600.

Mandel JS, Berlinger N, Kay N, Connett J, Reape M. Organo phosphate exposure inhibits nonspecific esterase staining in human blood monocytes. Am J Ind Med 1989; 15:207-212.
Olsen GW, Mandel JS, Gibson R, Wattenberg L, Schuman L. A case-control study of pancreatic cancer and cigarettes, alcohol and coffee. Am J Public Health 1989; 79:1016-1019.

Bender AP, Parker DL, Johnson RA, Anderson WK, Williams AN, Marbury MC, Mandel JS. The Minnesota highway maintenance worker study: Cancer mortality. Am J Ind Med 1989; 15:545-556.

Parker DL, Bender AP, Johnson R, Scharber W, Williams A, Marbury M. Minnesota highway maintenance worker cohort mortality study: Methods and noncancer mortality. Am J Ind Med 1989; 15:531-543.

Greenberg ER, Baron JA, Stevens MM, Stukel TA, Mandel JS, Spencer SK, Elias PM, Lowe N, Nierenberg DN, Bayrd G, Vance JC. The skin cancer prevention study: A design of a clinical trial of beta carotene among persons at high risk for nonmelanoma skin cancer. Controlled Clinical Trials 1989; 153-166.

Mandel JS, Bond J, Snover D, Williams S, Bradley M, Walker C, Schuman L, Gilbertsen V. The University of Minnesota's Colon Cancer Control Study: Design and progress to date. In: Screening for Gastrointestinal Cancer. Eds. Chamberlain, J. and Miller, A.B. Hans Huber Pub., Bern, 1988.

Olsen GW, Mandel JS. Selection of elderly controls using random digit dialing AJPH 1988; 78:1487-1488.

Lilienfeld DE, Mandel JS, Coin P, Schuman LM. Projection of asbestos-related diseases in the United States, 1985-2009. I Cancer Br J Indust Med 1988; 45:283-291.

Visscher W, Lonstein JE, Hoffman DA, Mandel JS, Harris B. Reproductive Outcomes in Scoliosis patients. Spine 1988; 13:1096-1098.

Bender AP, Williams AN, Sprafka JM, Mandel JS, Straub CP. Usefulness of comprehensive feasibility studies in environmental epidemiology investigations. A case study in Minnesota. AJPH 1988; 78:287-290.

Mandel JS, Bond JH. Sensitivity of fecal Hemoccult testing and flexible sigmoidoscopy for colorectal cancer screening. JOM 1987; 29:985-6.

Mandel JS, Schuman LM. Sexual factors and prostatic cancer: Results from a case-control study. J Gerontology 1987; 42:259-264.

Mandel JS. Cancer risk in radiologic technologists: A collaborative University of Minnesota - American Registry of Radiologic Technologists epidemiologic study. Radiologic Technology 1987; 58:261-268.

McLaughlin J, Blot W, Mehl E and Mandel J. Re: Problems in the use of dead controls in case-control studies. Am J Epidemiol 1985; 122:1108-1109.

Gerberich S, Hays M, Mandel J, Gibson R, Ven der Heide. Analysis of suicide in adolescents and young adults: Implications for prevention. In: Primary Health Care in the Making, Laaser, V. Senault, R. and Viethaus, H. Ed.Heidelberg, Springer-Verlag, 1985.

Levitt S, Mandel J. Breast carcinogenesis: Risk of radiation. Int J Radiat Oncol Biol Phys 1985; 11:1421-1423.

Osterholm M, Mandel J, Davis J, Gibson R. The impact of bias in the tri-state toxic shock syndrome study. Arch Intern Med 1985; 145:763.

McLaughlin J, Blot W, Mehl E and Mandel J. Problems in the use of dead controls in case-control studies. II The effects of excluding certain causes of death. Am J Epidemiol 1985; 122:485-494.

Lawler A, Mandel J, Schuman L, Lubin J. A retrospective cohort mortality study of iron-ore (hematite) miners in Minnesota. JOM 1985; 27:507-517.

Ramlow J, Halberg F, Prineas R, Mandel J. Automatic circadian 24-h profiles of systolic and diastolic pressure and radial pulse in black and white boys. Chronobiologia 1985; 12:76-77.

McLaughlin J, Blot W, Mehl E, Mandel J. Problems in the use of dead controls in case-control studies. I General Results. Am J Epidemiol 1985; 121:131-139.

Massey FJ, Bernstein GS, O'Fallon WM, Schuman LM, Coulson AH, Crozier R, Mandel JS et al. Vasectomy and health. Results from a large cohort study. JAMA 1984; 252:1023-1029.

Visscher W, Mandel J, Batalden P, Russ J, Giebink G. A case-control study exploring possible risk factors for childhood otitis media. In: Recent Advances in Otitis Media With Effusion, Lim D. Ed. B.C. Decker, Inc., Philadelphia, 1984.

Olsen G, Mandel J, Bender A. Evaluating pet facilitated therapy in long-term care facilities. In: The Pet Connection , Ed. Anderson, R.K., Censhare Pub., 1984.

Levitt S, Mandel JS. Benefit versus risk in radiation and conservation surgery for breast cancer. Am J Med 1984; 77:93-100.

McLaughlin JK, Blot WJ, Mandel JS, Schuman LM, Mehl E, Fraumeni JF. A population based case-control study of renal cell carcinoma. JNCI 1984; 72:275-284.

McLaughlin JK, Blot WJ, Mandel JS, Schuman LM, Mehl E, Fraumeni J. Cancer of the renal pelvis: Cigarette smoking and other risk factors. JNCI 1983; 71:287-291.

Levitt S, Mandel J. Breast irradiation and future risk of carcinogenesis. Front Radiat Ther Onc 1982; 17:131-142.

Osterholm M, Gibson R, Mandel J, Davis J. Tri-state toxic shock syndrome study: Methodologic analysis. Ann Int Med 1982; 96:899-902.

Osterholm MT, Davis JP, Gibson RW, Mandel JS, Wintermeyer LA, Helms CM, Forfang JC, Rondeau J, Vergeront JM. Tri-state toxic shock syndrome study: Epidemiologic findings. J Inf Dis 1982; 145:431-440.

Lawler A, Mandel JS, Schuman LM, Lubin JH. Mortality study of Minnesota iron miners: Preliminary results. Proceedings of Fourth Annual Rocky Mountain Center for Occupational and Environmental Health Conference, Ann Arbor Science, 1982.

McLaughlin JK, Mandel JS, Blot WJ, Schuman LM. A case-control study of kidney cancer. Am J Epidemiol 1982; 114:443 (abstract).

Sigurdson E, Levy B, Mandel JS, McHugh R, Michienzi L, Jagger H, Pearson J. Cancer morbidity investigations: Lessons from the Duluth study of possible effects of asbestos in drinking water. Environ Res 1981; 25:50-61.

Seal U, Mandel J, Radke A, Halberg F, Schuman L. Circannual endocrine variations in prostatic cancer patients and matched hospital and neighborhood controls. In: Proc. XIVth Int. Conf. Int. Soc. Chronobiol. Il Ponte, Milan, 1981.

Halberg F, Cornelissen G, Sothern RB, Wallach LA, Halberg E, Ahlgren A, Kuzel M, Radke A, Barbosa J, Goetz F, Buckley J, Mandel J et al. International Geographic Studies of Oncological Interest on Chronobiological Variables In: Neoplasms-Comparative Pathology of Growth in Animals, Plants and Man, H. Kaiser, Ed., Williams and Wilkens, Baltimore, 1981.

Schuman L, Mandel J, Radke A, Seal U, Halberg F. Some selected features of the epidemiology of prostatic cancer: Minneapolis-St. Paul case-control study. In: Trends in Cancer Incidence, Ed. Magnus, K., IUCC Monograph, Oslo, Norway, 1981.

Perry G, Spector B, Schuman L, Mandel JS, Anderson V, McHugh R, Hanson M, Fahlstrom S, Krivit W, Kersey J. The Wiskott-Aldrich syndrome in the United States and Canada. J Pediatrics 1980; 97:72-78.

Mandel JS, Schuman LM. The epidemiology of cancer of the prostate. In: Cancer Epidemiology, Lilienfeld, A.M., ed. Elsevier Publications, New York, 1980.

Mandel JS, Halberg F, Radke A, Seal US, Schuman L. Circannual variation in serum TSH and prolactin in prostatic cancer patients. Chronobiologia 1980; 7:129.

Schuman LM, Mandel JS. Prostatic cancer in blacks. J Prev Med 1980; 9:630-649.

McHugh R, Church T, Mandel J, White C. The parameterization of predictive value for multi-site screening. Biometrics 1980; 36:523-529.

Radke AQ, Halberg E, Hillman D, Halberg F, Haus E, Mandel J, Schuman L. Correlations between breast cancer risk and circannual rhythm characteristics as well as seasonal components of circannual rhythms. Chronobiologia 1980; 7:134-136.

Gilbertsen V, Church T, Grewe F, Mandel J, McHugh R, Schuman L, Williams S. The design of a study to assess occult-blood screening for colon cancer. J Chron Dis 1980; 33:107-114.

Radke A, Halberg F, Haus E, Kawasaki T, Mandel JS et al. Questionnaires complement tensopsy and hemopsy in chronoepidemiologic inquiries into risk of diseases associated with high blood pressure. Chronobiologia 1980; 7:131-132.

Radke AQ, Hillman DC, Cornellissen G, Mandel J, Schuman L, Halberg F. Correlation between individualized total breast cancer risk and imputed circannual amplitude of plasma prolactin. Proc. Minn. Acad. Sci. pp. 16-17, 1979.

Schuman LM, Mandel JS, Blackard C, Bauer H, Scarlett J, McHugh R. Epidemiologic study of prostatic cancer: Preliminary report. Cancer Treat Rep 1977; 61:181-186.

Hoxtell G, Mandel JS, Murray S, Schuman LM, Goltz RW. Incidence of skin carcinoma following renal transplantation. Arch Derm 1977; 113:436-438.

Levy B, Sigurdson E, Mandel JS, Laudon E, Pearson J. Investigating possible effects of asbestos in city water: Surveillance of gastrointestinal cancer incidence in Duluth, Minnesota. Am J Epidemiol 1976; 103:362-368.

Neri LC, Mandel JS, Hewitt D, Jurkowski D. Chronic obstructive pulmonary disease in two cities of contrasting air quality. Can Med Ass J 1975; 113:1043-1046.

Neri LC, Hewitt D, Schreiber GB, Anderson TW, Mandel JS, Zdrojewsky A. Health aspects of hard and soft water. JAWWA 1975; 67:403-409.

Neri L, Hewitt D, Mandel JS. Relation between mortality and water hardness in Canada. Lancet 1972; 1:931-934.

Neri L, Hewitt D, Mandel JS. Risk of sudden death in soft water areas. Am J Epidemiol 1971; 94:101-104.

Neri L, Mandel JS. A household survey of chronic obstructive pulmonary disease in Ottawa: Methodological problems and results of a pilot survey. Can J Pub Hlth 1970; 61:407-412.

Johnson G, Cooper J, Mandel JS. Expectation of admission to a Canadian psychiatric institution: Conditional expectancy measure. Can Psychiat Assn J 1969; 14:295-298.

Book Reviews

Mandel JS. A Review of Environmental Epidemiology: Epidemiologic Investigation of Community Environmental Health Problems by J. Goldsmith. J Public Health Policy, Autumn, 1988.

Mandel JS. A Review of Screening in Chronic Disease by A.S. Morrison. J Public Health Policy, Summer, 1987.

Presentations


Mandel J. Public Health in the 21st Century. What Should We Expect? Presented at 3rd Annual Symposium, Massey College. Toronto, Ontario. April 22, 2009

Mandel J. Colorectal Cancer Screening: Quality Determinants of FOBT. Presented at Colorectal Cancer Quality Determinants Workshop. Vancouver, BC, May 22-23, 2008

Mandel J. CRC Screening: Are We Doing Enough and Are We Doing It Right. Presented at University of Toronto, January 25, 2008

Mandel J. Principles of Cancer Screening. Presented at University of California, Berkeley, April 10, 2007

Mandel J. Critical Issues in the Design, Conduct and Analysis of Population-Based Colorectal Cancer Screening Program. Paper presented at Progamas Poblacionales para la Prevencion del Cancer de Colon y Recto en Espana. Murcia, Spain, February 22-23,2007

Mandel J. The Means and Evidence for Colorectal Cancer Screening. Paper presented at Public Health and Cancer Screening: Promises and Perils, Montreal, Quebec, October 26-27, 2006

Mandel J. Principles of Cancer Screening. Paper presented at Cancer Prevention and Early Detection, Beijing, China, April 21-24, 2006

Mandel J. Why Pay Attention to Prevention. Paper presented at Cancer Prevention and Early Detection, Beijing, China, April 21-24, 2006

Mandel J. Integrating CRC Screening into Practice. Paper presented at Cancer Prevention and Early Detection, Beijing, China, April 21-24, 2006

Mandel J. Screening Theory: Overdiagnosis in Cancer Screning. Paper presented at Palazzo dei Congressi, Florence, Italy, November 14-16, 2005

Mandel J. Methodological Issues in Cancer Prevention Trials: Examples from Colon and Prostate Cancer. Paper presented at University of South Carolina, October 13, 2004

Mandel J. Epidemiology of Prostate Cancer. Paper presented at Advances in Urology, Atlanta, Georgia, December 6, 2003

Mandel J. Colorectal Cancer Screening: The Nuts and Bolts for Effective Patient Care. Paper presented at Dialogue For Action: Increasing Cancer Screening Rates – The Colorectal Cancer Screening Model. Bethesda, MD, March 21, 2002

Mandel J. Epidemiology Studies of Vietnam Veterans: A Critical Review. Paper presented at Dioxin 2001. Korea. September 13, 2001

Mandel J. The Role of Public Health in the Prevention of Colon Cancer. Fourteenth Richard G. Bond Memorial Lecture, Minneapolis, Minnesota, October 12, 2000

Mandel J. Dioxin and Cancer. A Review of the Epidemiologic Evidence. Paper presented at International Society for Regulatory Toxicology and Pharmacology. Arlington, VA. Oct 6, 2000

Mandel J. Is FOBT Good Enough? Paper presented at the First Australian Collaborative Conference on Colorectal Cancer Prevention, Sydney, Australia, March 2-3, 2000

Mandel J. The PLCO (Prostate, Lung, Colorectal, Ovary) Trial. Paper presented at the International Conference on Prevention and Early Diagnosis of Lung Cancer, Varese, Italy, December 8-10, 1998.

Mandel J. Colorectal Cancer Screening. Paper presented at XVII UICC International Cancer Congress, Rio de Janeiro, Brazil, August 24-28, 1998.

Mandel J. Colorectal Cancer: To Screen or Not to Screen Is No Longer a Question. Paper presented at the Delta Omega Lecture, Tulane School of Public Health, New Orleans, LA,
March 10, 1998.

Mandel J. Fecal Occult Blood Screening Alone or with Flexible Sigmoidoscopy. Paper presented at Colorectal Cancer Screening Consensus Conference on Methodology and
Cost-Benefit, Tel Aviv, Israel, December 18, 1997.

Mandel J. Screening for Colorectal Cancer. Paper presented at 2nd Nottingham International Colorectal Cancer Symposium, Nottingham, England, October 23-24, 1997.

Mandel J. Current Mass Screening Programs. Paper presented at 52nd Annual Meeting of the German Society of Gastroenterology and Metabolism, Ludwigshafen, Germany, September
17-20, 1997.

Mandel J. Screening for Colorectal Cancer. The Minnesota Study. Paper presented at the Danish Cancer Society V Annual Symposium, Copenhagen, Denmark, August 17-20, 1997.

Mandel J. Colorectal Cancer Screening. Fecal Occult Blood Testing. Paper presented at American Society of Clinical Oncologists, Denver, Colorado, May 19-21, 1997.

Mandel J. Molecular Screening for Colorectal Cancer. Paper presented at the Third International Symposium on the Impact of Cancer Biotechnology on Diagnostic and Prognostic Indicators in Preventive Oncology and Therapy, Nice, France, October 26-28, 1996.

Mandel J. The Population Trials. Results from the Minnesota Study. Paper presented at European Group for Colorectal Cancer Screening, Visby, Sweden, September 13-14, 1996.

Mandel J. Screening for Colorectal Cancer. Paper presented at XXIII Congreso Nacional de la Sociedad Espanola de Patologia Digestiva, Sevilla, Spain, June 9-12, 1996.

Mandel J. Mass Screening Experience in the USA. Paper presented at the International Union Against Cancer (UICC) Colorectal Cancer Screening Workshop, Genoa, Italy, September 29, 1995.

Mandel J. Screening for Colorectal Cancer. The Minnesota Study. Paper presented at the European Group for Colorectal Cancer, Schloss Teupitz, Germany, September 21, 1995.

Mandel J. Indications for Screening Older Persons for Colorectal Cancer. Paper presented at the American Geriatrics Society 16th Annual Meeting, Washington, DC, May 20, 1995.

Mandel J. Prostate and Colorectal Cancer: Trends and Future Directions. Paper presented at the First Annual Cancer Prevention and Control Conference, Atlanta, Georgia, May 16, 1995.

Mandel J. Reducing Mortality from Colorectal Cancer by Screening for Occult Blood. Paper presented at the Twenty-Fifth Congress of the German Endoscopy Society, Munich, Germany, March 9-11, 1995.

Mandel J. Screening for Colorectal Cancer in the USA. Paper presented at the Second International Conference on Colorectal Tumors, Milan, Italy, September 11-14, 1994.

Mandel J. Screening for Colon and Rectal Cancer. Paper presented at Fifth Annual Cancer Conference, Orlando, Florida, September 1-4, 1994.

Mandel J. Fecal Occult Blood Testing: The University of Minnesota Study. Paper presented at International Workshop on Colorectal Cancer Screening, National Cancer Institute, Bethesda, Maryland, June 6-8, 1994.

Mandel J. Controversies in Cancer Screening: Colon Cancer. Paper presented at Family Medicine Today, Minneapolis, Minnesota, March 11, 1994.

Mandel J. A National Policy for Colorectal Cancer Screening. Paper presented at Centers for Disease Control, Atlanta, Georgia, March 15, 1994.

Mandel J. Screening for Colorectal Cancer. Is It Effective? Paper presented at Eighth National Conference on Chronic Disease Prevention and Control, Kansas City, Missouri, November 18, 1993.

Mandel J. Colorectal Cancer Screening. Paper presented at Principals of Colon and Rectal Surgery, Minneapolis, Minnesota, September 29-October 1, 1993.

Mandel J. Secondary Prevention of Colorectal Cancer. Paper presented at I International and VII National Congress on Hygiene and Preventive Medicine in Hospitals, Santiago de Compostela, Spain, September 22-25, 1993.

Mandel J. The Minnesota Screening Experience. Paper presented at European Group for Colorectal Cancer Screening Meeting, Dijon, France, August 25-28, 1993.

Mandel J. Colorectal Cancer Screening. Is it Justified? Paper presented at University of Michigan School of Public Health, July 21, 1993.

Mandel J. Screening for Colorectal Cancer Using Fecal Occult Blood Tests. Paper presented at University of Pittsburg and Shadyside Hospital, June 17, 1993.

Mandel J Methods of Cancer Screening. Paper presented at Hospital de la Princesa, Madrid, Spain, December 4, 1992.

Mandel J. Screening for Colorectal Cancer. The Minnesota Experience. Paper presented to XV Reunion Cientifica de la Asociacion Castellana de Aparato Digestivo, Guadalajara, Spain, October 2-3, 1992.

Mandel J. Screening Asbestos Exposed Workers. Paper presented at 3M, Minneapolis, Minnesota, October 16, 1991.

Mandel J. Epidemiology: Principles and Methods. Paper presented at 3M, Minneapolis, Minnesota, April 16, 1991.

Mandel J. A review of epidemiologic studies on EMF exposure and cancer. Paper presented to EMF Seminar for Senior Management, Northern Electric Light and Power Association, Portland, Oregon, June 14, 1989.

Mandel J. Mass Screening for Colorectal Cancer: Is It Justified? Paper presented at Mary A. Davis Memorial Symposium, "Early Detection of Cancer: Potential for Increased Survival and Cures", Pittsburgh Cancer Institute, November 19, 1988.

Mandel J. Epidemiology in Toxic Tort Litigation. Paper presented at Toxic Torts Seminar, Minneapolis, Minnesota, July 27, 1988.

Mandel J. Issues and Recommendations in Screening for Colorectal Cancers. Paper presented at American Society for Preventive Oncology, Bethesda, Maryland, March 14, 1988.

Mandel J. Screening for Colorectal Cancer. The United States Experience. Paper presented at Twenty-third International Medical Meeting, Monza, Italy, June 5, 1987.

Mandel J. Colon Cancer Screening: An Issue for the Workplace. Paper presented at The Mount Sinai Medical Center, New York, NY, November 21, 1986.

Mandel J. The University of Minnesota Colon Cancer Control Study. Paper presented at the UICC Symposium on Colon Cancer Screening, Gothenberg, Sweden, November 4-7, 1985.

Mandel J. Status report: University of Minnesota/ARRT study of cancer risk among radiologic technologists. Paper presented at the ARRT Invitational Symposium, Denver, Colorado, June 22, 1985.

Mandel J. Methodological issues in the study of long-term health effects associated with vasectomy, University of Manitoba, November 23, 1984.

Schuman LM and Mandel JM. Methodological issues in screening: The University of Minnesota study and screening for colorectal cancer. Paper presented at Society for Epidemiologic Research, Winnipeg, Manitoba, June 14-17, 1983.

Olsen G, Mandel J and Bender A. Epidemiologic strategies and methods to evaluate pet facilitated therapy in long term care facilities. Paper presented at Human-Animal Bond Conference, Minneapolis, Minnesota, June 13-14, 1983.

Lawler A., Mandel J, Schuman L and Lubin J. A methodologic issue in occupational mortality studies: Selection of an appropriate comparison group. Paper presented to Society for Epidemiologic Research, Winnipeg, Manitoba, June 14-17, 1983.

Mandel J. Prevention of cancer by naturally occurring and synthetic compounds. Paper presented to American Cancer Society, 42nd Annual Meeting, Minneapolis, Minnesota, October 8-9, 1982.

Levitt SH and Mandel J. Breast irradiation and future risks of carcinogenesis. Paper presented to Seventeenth Annual Cancer Symposium, San Francisco, California, February 27-28, 1982.

Mandel J. Assessing health status, identifying health risks and evaluating the efficacy of health programs for industry. Paper presented at conference on The Expanding Role of Occupational Medicine, Charleston, South Carolina, October 1-3, 1981.

Mandel J., Control selection in case-control studies. Paper presented to Society for Epidemiologic Research, Snowbird, Utah, 1981.

Radke AQ, Halberg F, Haus E, Kawasaki T, Mandel J, Halberg E, Schuman L, Lakatua D, Ueno M, Uezono K, Matsuoka M and Omae T. Questionnaires complement tenopsy and hemospy in chronoepidemiolgic inquiry into risk of diseases associated with high blood pressure. Proc. 3rd Conf. Indian Soc. Chronobiol., Varansi, India, Dec. 27-29, 1979.

Radke AQ, Hillman DC, Cornelissen G, Mandel JS, Schuman LM, Halberg F. Correlation between individualized total breast cancer risk and imputed circannual amplitude of plasma prolactin. Minn. Acad. Sci. 47th Annual Spring Meeting, University of Minnesota, Morris, May 4-5, 1979.

Mandel J, Halberg F, Radke A, Seal U and Schuman L. Circannual variation in serum TSH and prolactin of prostatic cancer patients. Proc. 3rd Conf. Indian Soc. Chronobiol., Varanasi, India, Dec. 27-29, 1979.

Schuman LM and Mandel JS. Prostatic cancer in blacks. Proceedings of a Workshop on Esophageal and Prostatic Cancer: The Basis for Black-White Difference in Incidence, Washington, D.C., October 23, 1979.

Sigurdson E, Levy B, Mandel JS et al. Cancer morbidity investigations: Lessons from the Duluth study of possible effects of asbestos in drinking water. Paper presented to the Second Workshop on Health Surveillance Around Point Sources of Pollution, Albuquerque, New Mexico, January 22-24, 1979.

Sigurdson E, Mandel JS, McHugh RB, Michienzi L, Levy B and Jagger H. Investigating possible effects of amphibole fibers in city water: Surveillance of cancer incidence in Duluth. Paper presented to the American Public Health Association, Los Angeles, California, 1978.

Windler C, Mandel J and McHugh R. Test predictivity in multi-site cancer screening. Paper presented to the American Public Health Association, Washington, D.C., 1977.

Mandel JS. Epidemiologic study of etiologic factors in prostatic cancer. Paper presented to Society for Epidemiologic Research, Seattle, Washington, 1977.

Neri L, Hewitt D, Schreiber G and Mandel JS. Is there a water factor: A case for magnesium. Paper presented to Seventh International Water Quality Symposium, Washington, D.C., 1974.

Neri L, Mandel JS, Hewitt D and Jurkowski D. Chronic obstructive pulmonary disease in two Ontario communities. Paper presented to International Epidemiologic Association, Brighton, England, 1971.

Neri L, Mandel JS and Davies J. Household survey for chronic respiratory disease in Ottawa. Paper presented to the Canadian Thoracic Society, Toronto, Ontario, 1971.

Neri L and Mandel JS. Epidemiologic survey of respiratory disease in Ottawa. Paper presented to the Canadian Thoracic Society, Toronto, Ontario, 1970.

Neri L and Mandel JS. The relationship between water hardness and cardiovascular mortality. The Canadian experience. Paper presented to the Society for Epidemiologic Research, Minneapolis, Minnesota, 1970.

Prior Experience

Professor and Director, Dalla Lana School of Public Health, University of Toronto, 2008-10

Rollins Professor and Chairman, Dept. of Epidemiology, Rollins School of Public Health, Emory University, 2002-08

Professor, Dept. Hematology and Oncology, School of Medicine, Emory University, 2003-08

Georgia Cancer Coalition Distinguished Cancer Scholar, 2003-08

Deputy Director, Cancer Control and Population Sciences, Winship Cancer Institute, 2007-08

Consulting Professor, School of Medicine, Stanford University, 2000-02

Adjunct Professor, School of Medicine, University of California, San Francisco, 2001-02 

Group Vice President, Exponent Inc., 1999-02

Head, Division of Environmental and Occupational Health School of Public Health, University of Minnesota, 1995-99

Professor, Division of Environmental and Occupational Health, School of Public Health, University of Minnesota, 1988-99

Mayo Chair in Public Health, University of Minnesota, 1996-99

Director of Graduate Studies, Division of Environmental and Occupational Health School of Public Health, University of Minnesota, 1989-95

Instructor, Midwest Occupational Health Institute, University of Minnesota, 1983-88

Associate Professor, Division of Environmental Health, School of Public Health, University of Minnesota, 1984-88 

Instructor, Graduate Summer Session in Epidemiology, University of Minnesota, 1980-85

Assistant Director, Division of Epidemiology, School of Public Health, University of Minnesota, 1979-83

Director of Graduate Studies, Division of Epidemiology, University of Minnesota 1982-84

Associate Professor, Division of Epidemiology, School of Public Health, University of Minnesota, 1981-84

Assistant Professor, Division of Epidemiology, School of Public Health, University of Minnesota, 1980-81

Instructor, Division of Epidemiology, School of Public Health, University of Minnesota, 1975-80

Assistant Professor, Department of Epidemiology and Community Medicine, University of Ottawa, 1974-75

Lecturer, Department of Epidemiology and Community Medicine, University of Ottawa (Leave of absence, 1972-5) 1969-74 

Acting Senior Analyst, Health and Welfare Division, Statistics Canada, Ottawa, 1968-69

Statistician, Health and Welfare Division, Statistics, Canada, Ottawa, 1967-68

Academic Appointments

Deputy Chair, Council of Health Sciences, University of Toronto (2009-10)

Member, Neurosciences Leadership Committee, Emory University (2008)

Woodruff Health Sciences Strategic Plan Steering Committee, Vision 2012, Emory University (2005-6)

Medical Sciences Discovery Subcommittee, Medical Curriculum Planning Committee, Emory University (2005-6)

Research Advisory Committee, Emory University (2003-8)

Associate Director, Population Sciences and Cancer Control,Winship Cancer Center, Emory University (2002-8)

Executive Leadership Committee, Winship Cancer Institute, Emory University ( 2003-8)

Member, Judicial Committee, University of Minnesota (1995-8)

Policy Council, School of Public Health, University of Minnesota (1995-9)

Chairman, Health Sciences Policy and Review Council, University of Minnesota (1995)

Advisory Committee, Tulane University School of Public Health, Environmental Center Development Grant (1994-5)

Chairman, Appointments, Promotions and Tenure Committee, School of Public Health, University of Minnesota (1993-5)

Faculty Consultative Committee, School of Public Health, University of Minnesota (1992-3)

Appointments Promotions and Tenure Committee, School of Public Health, University of Minnesota (1992-4)

Chairman, Graduate Faculty Nominations Committee, University of Minnesota (1990-3)

Co-Chairman, Faculty Consultative Committee, School of Public Health, University of Minnesota (1990-2)

Advisory Committee, Johns Hopkins School of Hygiene, Environmental Health Center (1990-6)

Health Sciences Policy and Review Council, University of Minnesota Graduate School (1989-94)

Internal Review Committee, School of Public Health, University of Minnesota (1989)

Task Force on Industry / School of Public Health Relationships, University of Minnesota (1989)

Advisory Committee, Environmental Epidemiology Training Program, Mount Sinai Medical Center of New York (1988-93)

Administrative Council, School of Public Health, University of Minnesota (1987-90)

Faculty Senate, University of Minnesota (1987-90)

Appointments, Promotions and Tenure Committee, School of Public Health, University of Minnesota (1986-90)

Advisory Committee, Immunodeficiency and Cancer Registry, Department of Pathology, University of Minnesota (1984-6)

Steering Committee, Cariology Training Program School of Dentistry, University of Minnesota (1984-6)

Appointments, Promotions and Tenure Committee, School of Public Health, University of Minnesota (1981-3)

Member, Planning Committee, Graduate Summer Session in Epidemiology, University of Minnesota / University of Michigan (1983-5)

Research Advisory Committee, Department of Family Practice and Community Health, University of Minnesota (1983-97)

Administrative Council, School of Public Health, University of Minnesota (1983-6)

Faculty Senate, University of Minnesota (1983-6)

Faculty Consultative Committee, School of Public Health, University of Minnesota (1982-3)

Faculty Advisor, Council of Graduate Students, University of Minnesota (1983-4)

Constitutional Review Committee, School of Public Health, University Minnesota (1982)

Research Committee, School of Public Health, University of Minnesota (1982-3)

Educational Policy Committee, School of Public Health, University of Minnesota (1980-3)

Committee on Committees, School of Public Health, University of Minnesota (1980-2)

Planning Council, School of Public Health, University of Minnesota (1978-1981)

Grievance Committee, School of Public Health, University of Minnesota (1977-1980)

Executive Subcommittee on Policy, Use of Human Subjects in Research, University of Minnesota (1977-1980)

Research Committee, School of Public Health, University of Minnesota (1977-1980)

Space Planning Committee, School of Public Health, University of Minnesota (1977-9)

Committee on the Use of Human Subjects in Research, University of Minnesota (1976-1984)

Additional Information

Advisory Appointments

Member, Early Detection, Quality of Life Outcomes Workgroup, American Cancer Society (2010-)

DRI Chronic Disease Indicators, Institute of Medicine (2009)

Incidence and Mortality Committee, American Cancer Society (2008-9)

Member, Colorectal Clinical Studies Group Review, National Cancer Research Institute, UK (2008)

Member, Awards Committee, American College of Epidemiology (2007-10)

Chair, Review Committee, Health Promotion and Disease Prevention Research Centers, Special Interest Project Supplements, CDC (2007)

Member, Joint Colorectal Cancer Screening Guidelines Review Committee American Cancer Society (2006-8)

Chair, Review Committee, Determinants of Receiving Radiation Therapy after Breast Conserving Surgery Among Low Income Women, CDC (2006)

Member, National Academy of Sciences, Review of DOE Worker Studies (2005-6)

Chair, Special Emphasis Panel, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (2005)

Colorectal Cancer Roundtable, Chemoprevention and Emerging Technologies

Task Force, American Cancer Society (2003-8)

Chairman, Health Effects Panel, CH2M Hill, Hanford, WA (2003-5)\

Breast and Cervical Cancer Early Detection and Control Advisory Committee, Centers for Disease Control and Prevention (1999-2000)

Chairman, Scientific Advisory Committee on Brain Cancer Cluster, Stillwater, Minnesota, (1995-6)

Chairman, Koch Refinery Task Force, Pine Bend, Minnesota (1994-6)

State Preventive Health Advisory Committee, Minnesota Department of Health (1993-8)

Chairman, Scientific Advisory Committee, American Forest and Paper Association (1991-8)

Air Toxics Technical Advisory Committee, Minnesota Pollution Control Agency (1990-2)

Grants Committee, Minnesota Association of Public Teaching Hospitals (1991-3)

Consultant, "Colorecord Study" (Fox Chase Cancer Center) (1988-92)

Consultant, "General Electric Advisory Group for PCB Studies" (1988-90)

Chairman, Highland Park - Ford Motor Company Task Force (1987-9)

Biometry and Epidemiology Contract Review Committee, National Cancer Institute (1986-90)

Education Committee, American College of Epidemiology (1986-9)

Governing Council, American Public Health Association (1986-7)

International Affairs Committee, American College of Epidemiology (1984-7)

Co-chairman, Task Force on Examinations, American College of Epidemiology (1983-5)

Executive Committee, Society for Epidemiologic Research (1980-3)

Consultant, U.S. Air Force Study of Agent Orange (1980-2)

Epidemiology Section, Program Planning Committee, American Public Health Association (1980-1)

Chairman, Breast Cancer Detection Task Force, Minnesota Health Department (1976-80)

Epidemiology Committee, American Cancer Society (1974-80)

Editorships and Editorial Review Boards

Associate Editor, Journal of Medical Screening (2009-)

Editorial Committee, Journal of Medical Screening (2007-9)

Associate Editor, American Journal of Epidemiology (1992-7)

Chairman, Editorial Board, Health and Environment Digest (1986-93)

CREDENTIALS & PROFESSIONAL HONORS

  • Ph.D., Epidemiology, University of Minnesota, 1981
  • M.P.H., Epidemiology, University of Minnesota, 1973
  • B.Sc., Mathematics, University of Manitoba, 1966
  • Georgia Cancer Coalition Distinguished Cancer Scholar, 2003–2008

    Leonard M. Schuman Award for Excellence in Teaching, 1997

    Excellence in Teaching Award, 1988–1989

    Health Scientist Fellowship from the Department of National Health and Welfare, Ottawa, Canada, 1972–1975